Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Pharmaceuticals (Basel) ; 15(7)2022 Jun 29.
Article in English | MEDLINE | ID: mdl-35890108

ABSTRACT

Linearolactone (LL) is a neo-clerodane type diterpene that has been shown to exert giardicidal effects; however, its mechanism of action is unknown. This work analyzes the cytotoxic effect of LL on Giardia intestinalis trophozoites and identifies proteins that could be targeted by this active natural product. Increasing concentrations of LL and albendazole (ABZ) were used as test and reference drugs, respectively. Cell cycle progression, determination of reactive oxygen species (ROS) and apoptosis/necrosis events were evaluated by flow cytometry (FCM). Ultrastructural alterations were analyzed by transmission electron microscopy (TEM). Ligand-protein docking analyses were carried out using the LL structure raised from a drug library and the crystal structure of an aldose reductase homologue (GdAldRed) from G. intestinalis. LL induced partial arrest at the S phase of trophozoite cell cycle without evidence of ROS production. LL induced pronecrotic death in addition to inducing ultrastructural alterations as changes in vacuole abundances, appearance of perinuclear and periplasmic spaces, and deposition of glycogen granules. On the other hand, the in silico study predicted that GdAldRed is a likely target of LL because it showed a favored change in Gibbs free energy for this complex.

2.
J Nat Prod ; 83(12): 3671-3680, 2020 12 24.
Article in English | MEDLINE | ID: mdl-33231455

ABSTRACT

Linearolactone (1) and kaempferol (2) have amebicidal activity in in vitro studies. The type of cell death induced by 1 and 2 and their effects on the virulence of E. histolytica were analyzed by transmission and confocal electron microscopy, reactive oxygen species (ROS) production, and apoptosis, detected by flow cytometry with dichlorofluorescein 2',7'-diacetate and annexin-V binding, respectively, and confirmed by TUNEL. The interaction of 1 and 2 with actin was analyzed by docking, and the in vivo amoebicidal activity was established with the Mesocricetus auratus model; amebic liver abscess (ALA) development was evaluated by magnetic resonance (MR) and validated post mortem. In vitro, compounds 1 and 2 caused chromatin condensation, intracellular ROS, and loss of actin structures. Coupling analysis showed that they bind to the allosteric and catalytic sites of actin with binding energies of -11.30 and -8.45 kcal/mol, respectively. Treatments with 1 and 2 induced a decrease in ALA formation without toxic effects on the liver and kidney. Thus, compound 1, but not 2, was able to induce apoptosis-like effects in E. histolytica trophozoites by intracellular production of ROS that affected the actin cytoskeleton structuration. In vivo, compound 1 was more active than compound 2 to reduce the development of ALA.


Subject(s)
Actin Cytoskeleton/drug effects , Diterpenes, Clerodane/pharmacology , Kaempferols/pharmacology , Liver Abscess, Amebic/prevention & control , Animals , Cricetinae , Cricetulus , Humans , Molecular Docking Simulation
3.
Molecules ; 24(3)2019 Feb 11.
Article in English | MEDLINE | ID: mdl-30754621

ABSTRACT

Peptic ulcers are currently treated with various drugs, all having serious side effects. The aim of this study was to evaluate the gastroprotective activity of calein D (from Calea urticifolia), a sesquiterpene lactone with a germacrane skeleton. Gastric lesions were induced in mice by administering ethanol (0.2 mL) after oral treatment with calein D at 3, 10 and 30 mg/kg, resulting in 13.15 ± 3.44%, 77.65 ± 7.38% and 95.76 ± 2.18% gastroprotection, respectively, to be compared with that of the control group. The effect found for 30 mg/kg of calein D was not reversed by pretreatment with NG-nitro-l-arginine methyl ester (l-NAME, 70 mg/kg, ip), indomethacin (10 mg/kg, sc) or N-ethylmaleimide (NEM, 10 mg/kg, sc). Hence, the mechanism of action of calein D does not involve NO, prostaglandins or sulfhydryl compounds. Calein D was more potent than carbenoxolone, the reference drug. The findings for the latter are in agreement with previous reports.


Subject(s)
Asteraceae/chemistry , Ethanol/adverse effects , Lactones/administration & dosage , Sesquiterpenes, Germacrane/administration & dosage , Stomach Ulcer/prevention & control , Animals , Disease Models, Animal , Dose-Response Relationship, Drug , Ethylmaleimide/administration & dosage , Ethylmaleimide/pharmacology , Indomethacin/administration & dosage , Indomethacin/pharmacology , Lactones/chemistry , Lactones/pharmacology , Mice , Molecular Structure , NG-Nitroarginine Methyl Ester/administration & dosage , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide/metabolism , Plant Extracts/administration & dosage , Plant Extracts/chemistry , Plant Extracts/pharmacology , Prostaglandins/metabolism , Sesquiterpenes, Germacrane/chemistry , Sesquiterpenes, Germacrane/pharmacology , Stomach Ulcer/chemically induced , Stomach Ulcer/metabolism , Sulfhydryl Compounds/metabolism
4.
Drug Dev Res ; 79(1): 11-15, 2018 02.
Article in English | MEDLINE | ID: mdl-29076166

ABSTRACT

Hit, Lead & Candidate Discovery The gastroprotective effect of calealactone B, isolated from Calea urticifolia was assessed in an ethanol-induced model of gastric lesioning. The possible involvement of prostaglandins, nitric oxide (NO) and sulfhydryl groups in the mechanism of action of calealactone B was also assessed. Calealactone B inhibited ethanol-induced gastric injuries with a maximal effect (95.3 ± 2.6%) at 30 mg kg-1 . A similar value was obtained at 10 mg kg-1 (83.5 ± 7.7%). Meanwhile, the reference anti-ulcer drug, carbenoxolone, an 11ß-hydroxysteroid dehydrogenase (11ß-HSD) inhibitor administered at 30 mg kg-1 showed 63.5 ± 9.4% gastroprotection. Hence, calealactone B was more potent than carbenoxolone. Pretreatment with indomethacin, L-NAME or NEM did not reverse the effects of calealactone B, indicating that prostaglandins, NO and sulfhydryl compounds do not participate in its mechanism of action.


Subject(s)
Anti-Ulcer Agents/therapeutic use , Lactones/therapeutic use , Stomach Ulcer/drug therapy , Animals , Anti-Ulcer Agents/pharmacology , Ethanol , Lactones/pharmacology , Male , Nitric Oxide/metabolism , Prostaglandins/metabolism , Rats, Wistar , Stomach Ulcer/chemically induced , Stomach Ulcer/metabolism , Sulfhydryl Compounds/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...